| Document Date: 2010-04-08 02:14:34
Open Document File Size: 316,77 KBShare Result on Facebook
City Key / / Country Australia / / Currency CYP / pence / / / IndustryTerm treatment of depression / food / treatment of major depressive disorder / / MedicalCondition insomnia / major depressive disorder / schizophrenia / headache / urinary retention / gastric irritation / urinary incontinence / nausea / mania / severe nausea / sexual dysfunction / acute narrow angle glaucoma / tremor / hepatic injury / serotonin syndrome / myocardial infarction / postural hypotension / disorder / pre-existing liver disease / tachycardia / end stage renal disease / hepatitis / dizziness / constipation / liver disease / depression / seizure disorders / bipolar disorder / / MedicalTreatment psychological therapies / / Organization Pharmaceutical Benefits Advisory Committee / North Metropolitan Area Health Service / / Person Karolinka Golebiewski / Katie Walker / Rajan Iyyalol References / / Position Governor / General / / Product venlafaxine / Seroquel XR / mirtazapine / Clozapine / fluoxetine / Some / escitalopram / Pristiq / Cymbalta / Both / / Technology alpha / Pharmacokinetics / CGI / /
SocialTag |
Graylands Hospital Drug Bulletin Desvenlafaxine and Duloxetine – new antidepressants North Metropolitan Area Health Service-Mental Health March 2009 Vol 16 No.1 ISSN[removed]